TMCnet News
RainDance Technologies Names Martin M. Coyne II and Glenn P. Muir to Board of Directors [Health & Beauty Close - Up](Health & Beauty Close - Up Via Acquire Media NewsEdge) RainDance Technologies has appointed Martin M. Coyne II and Glenn P. Muir to its Board of Directors. According to a company release, Coyne currently serves as a director of Akamai, a role he has held since November 2001. Before his retirement from Eastman Kodak in July 2003, he served in a variety of senior management positions including President of Health Imaging, President of the Commercial Business Group and most recently, Executive Vice President of Eastman Kodak and Group Executive of the Photography Group. "At its core RainDance is a technology company providing customers and partners with the ability to extract precise genetic data," Coyne said. "It's an exciting time to be at the intersection of healthcare and technology and to capitalize on genomics 'big data' trends as well as to be at the vanguard of fluid biopsy research of cancers and other complex diseases. I look forward to working with the board and leadership team to help the company continue its success." "Marty is a pioneer in digital content and big data. He served as Akamai's Lead Director from May 2003-May 2013 while the company grew from an Internet startup to almost $1.5B in revenue," said Roopom Banerjee, RainDance Technologies President and CEO. "At Eastman Kodak Marty was responsible for $9B in revenue overseeing businesses each with 'razor-blade' models. His operating experience along with his extensive knowledge of the healthcare industry -- including former management roles in sales, international marketing and business development at E.R.Squibb and Sterling Drug -- will help the company develop its markets and further build a loyal customer base." Muir has experience in financial management having guided Hologic from its early days with less than $10 million in revenue to its current position as one of the largest life science companies with annual revenues of over $2 billion. Currently the Audit Committee Chair at ReWalk Robotics, his Board of Director experience also includes Hologic from 2001 to 2013 and Vivid Technologies from 1996 until the company was sold to EG&G in 1999. Banerjee noted, "Glenn has built world-class organizations, has led the acquisition/integration of over twenty companies and has substantial financing experience with private and public companies. His healthcare industry experience spans medical imaging, diagnostics and surgical solutions. We are pleased to add his exceptional talents to our board." Muir added, "RainDance is helping researchers around the world unlock critical new insights and data from genetics. In doing so, it is playing a key role in opening up a world of discovery for researchers and advancing the understanding of disease development. I look forward to working with the board and leadership team." More information and complete details: www.RainDanceTech.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |